日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

DNA Repair Enzyme Regulation Strategy for Enhanced Pancreatic Neuroendocrine Tumor Therapy via Targeting siRNA-Lipid Nanoparticles

通过靶向siRNA-脂质纳米颗粒增强胰腺神经内分泌肿瘤治疗的DNA修复酶调控策略

Wang, Fei; Li, Yan; Xu, Junfeng; Tang, Wei; Xu, Xiaowu; Lou, Xin; Jing, Desheng; Fan, Guixiong; Qin, Yi; Chen, Jie; Yu, Xianjun; Cai, Weibo; Tang, Zhongmin; Ji, Shunrong

ACSL5 Regulates Glucose Metabolism and Chemotherapy Sensitivity in Colorectal Cancer Cells under Glutamine Deficiency

ACSL5在谷氨酰胺缺乏的情况下调节结直肠癌细胞的葡萄糖代谢和化疗敏感性

Tian, Shuai; Zhang, Qiaoxia; Sun, Xuedan; Thorne, Rick Francis; Shi, Zeyuan; Ji, Qiang; Sun, Zhangran; Lu, Yuanxiang; Zhao, Qun; Yu, Xianjun; Hu, Wanglai; Wu, Mian

Mitochondrial DNA mutations and intercellular mitochondrial transfer in cancer: mechanisms, biological effects, and clinical potential

癌症中的线粒体DNA突变和细胞间线粒体转移:机制、生物学效应和临床潜力

Chen, Yijia; Shi, Hanzhe; Xiao, Mingming; Pan, Haoqi; Yu, Xiaoning; Zhu, Yicheng; Yang, Jing; Wang, Wei; Xu, Jin; Yu, Xianjun; Shi, Si

Overcoming multidimensional immunotherapy resistance in PDAC: from microenvironment to clinic

克服胰腺导管腺癌的多维度免疫治疗耐药性:从微环境到临床

Yan, Jin; Ou, Huiyi; Wang, Shuai; Jin, Kaizhou; Yu, Xianjun; Wu, Weiding

Low-dose Simvastatin protects pancreatic cancer cells by promoting mitochondrial autophagy through TFEB.

低剂量辛伐他汀通过 TFEB 促进线粒体自噬,从而保护胰腺癌细胞。

Wang Zhiliang, Wu Di, Zhang Yue, Chen Weibo, Fan Shupei, Yang Yang, Yang Yue, Zu Guangchen, An Yong, Jin Yuchi, Kang Aining, Zou Yanxun, Liu Yi, Yu Xianjun, Qin Yi, Xu Xiaowu, Chen Xuemin

The CHPT-pSTAT3-SLC7A11 signaling axis controls progression and ferroptosis susceptibility of pancreatic cancer

CHPT-pSTAT3-SLC7A11信号轴控制胰腺癌的进展和铁死亡敏感性

Yang, Jianhui; Liu, Jiang; Rong, Zeyin; Tan, Zhen; Wang, Wei; Meng, Qingcai; Wei, Miaoyan; Hua, Jie; Zhang, Bo; Yu, Xianjun; Xu, Jin; Liang, Chen

A phase 1b/2 study of first-line anti-PD-L1/ TGF-βRII fusion protein SHR-1701 combined with nab-paclitaxel and gemcitabine for advanced pancreatic ductal adenocarcinoma

一项针对晚期胰腺导管腺癌的一线抗PD-L1/TGF-βRII融合蛋白SHR-1701联合白蛋白紫杉醇和吉西他滨的1b/2期研究

Xue, Ran; Wei, Miaoyan; Yuan, Jiajia; Li, Zhihua; Zhou, Yuhong; Xue, Zeyun; Wu, Yiwen; Han, Hongxia; Zhou, Jun; Yu, Xianjun; Shen, Lin

CLDN18.2-targeting antibody-drug conjugate IBI343 in advanced gastric or gastroesophageal junction adenocarcinoma: a phase 1 trial

CLDN18.2靶向抗体药物偶联物IBI343治疗晚期胃癌或胃食管交界处腺癌:一项I期试验

Liu, Jia; Yang, Jianwei; Sun, Yuping; Gong, Jifang; Yue, Jinbo; Pan, Yueyin; Sun, Meili; Song, Rongfeng; Xiao, Xiuying; Tazbirkova, Andrea; Ruan, Jian; Liu, Zhenyang; Liu, Zimin; Li, Zhihua; Sheng, Lili; Qin, Yanru; Ying, Jieer; Yu, Xianjun; Zhang, Jian; Mou, Yiping; Lu, Chuangxin; Chen, Ping; Li, Suyi; Li, Jie; Qu, Xiujuan; Deng, Ting; Du, Juan; Zhou, Aiping; Li, Enxiao; Yuan, Xianglin; Liang, Xinjun; Yu, Weiming; Morris, Michelle; Luo, Yang; Zhao, Xin; Guo, Yingmei; Zhou, Hui; Shen, Lin

TPX2 serves as a novel target for expanding the utility of PARPi in pancreatic cancer through conferring synthetic lethality

TPX2 是一种新型靶点,可通过赋予合成致死性来扩展 PARPi 在胰腺癌中的应用。

Xiao, Mingming; Tang, Rong; Pan, Haoqi; Yang, Jing; Tong, Xuhui; Xu, He; Guo, Yanmei; Lei, Yalan; Wu, Di; Lei, Yubin; Han, Yamei; Ma, Zhilong; Wang, Wei; Xu, Jin; Yu, Xianjun; Shi, Si

Histone lactylation-driven feedback loop modulates cholesterol-linked immunosuppression in pancreatic cancer

组蛋白乳酸化驱动的反馈环路调节胰腺癌中胆固醇相关的免疫抑制

Yang, Jing; Yu, Xiaoning; Xiao, Mingming; Xu, He; Tan, Zhen; Lei, Yubin; Guo, Yanmei; Wang, Wei; Xu, Jin; Shi, Si; Yu, Xianjun